| Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
München (Munich) |
| Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Regensburg |
| Zorbas, Haralabos (Bayern (govt) 201307 Managing Director of IBB Netzwerk GmbH) |
Managing Director |
Bavaria (govt region) |
Martinsried |
| Zolghadr, Kourosh (ChromoTek 201403 Head of RnD) |
Research & Development Manager |
ChromoTek GmbH |
Martinsried |
| Zobel, Peter Hanns (Bayern (govt) 201606 Director at IZB) |
Managing Director |
Bavaria (govt region) |
Martinsried |
| Zimmermann, Frank (Biomax Informatics 201710 Director Business Development) |
Business Development Manager / Strategy Manager |
Biomax (Group) |
Martinsried |
| Zimmer, Franz-Josef (Grünecker, Kinkeldey, Stockmair & Schwanhäusser 200809 Munich) |
n. a. |
Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR |
München (Munich) |
| Zilian, Olav (Medigene 201601– SVP Corporate Development before Helvea SA + ISREC) |
Business Development Manager / Strategy Manager |
Medigene (Group) |
Martinsried |
| Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Neuherberg |
| Zech, Birgit (Gotham Therapeutics 201708– COO before X-Rx + MAB Discovery + Pieris + Axxima) |
Business Development Manager / Strategy Manager |
Gotham Therapeutics (Group) |
Martinsried |
| Zaby, Andreas (Curacyte 200601) |
n. a. |
Curacyte (Group) |
München (Munich) |
| Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Indianapolis, IN |
| Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Martinsried |
| Yildiz, Murat (Avergen Pharmaceuticals GmbH 201510– Managing Director) |
Managing Director |
Avergen Pharmaceuticals GmbH (APG) |
Martinsried |
| Woods, Kate (Northbank 200411) |
n. a. |
Instinctif Partners (Group) |
München (Munich) |
| Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) |
Business Development Manager / Strategy Manager |
AMSilk GmbH |
Martinsried |
| Wodarz, Katharina (McDermott Will & Emery 201702 Partner in Munich) |
Attorney / Lawyer |
McDermott Will & Emery (MWE) (Group) |
München (Munich) |
| Wocheslander, Franz (Bayern Kapital 201112 Investment Manager) |
Investment Manager |
Bavaria (govt region) |
Landshut |
| Wixforth, Achim (Advalytix co-founder) |
n. a. |
Danaher (Group) |
München (Munich) |
| Wittmeier, Sebastian (Curefab GmbH 2008– CTO + Co-founder) |
Chief Technology/Technical Officer (CTO) |
Curefab GmbH |
München (Munich) |
| Winzer, Ludwig (Ocimum Germany GmbH 200606– Managing Director) |
Managing Director |
Ficus Enterprises (Group) |
Ebersberg |
| Wimmer, Sylvia (Wilex 201403 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Heidelberg Pharma (Group) |
München (Munich) |
| Wimmer, Bernhard (BioM AG 200603) |
Investment Manager |
Bavaria (govt region) |
Martinsried |
| Wimmer, Bartl (Synlab 201408 Managing Director) |
Managing Director |
Synlab (Group) |
Augsburg |
| Williams, James (Siemens 201304 CEO of Siemens Molecular Imaging business unit) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Erlangen |
| Wilhelmsson, Claes |
Investment Manager |
Investor AB (Wallenberg) (Group) |
Sweden_oo |
| Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO) |
Chief Executive Officer (CEO) |
Therawis (Group) |
München (Munich) |
| Wilckens, Thomas (InnVentis 201409) |
n. a. |
InnVentis Ltd. |
München (Munich) |
| Wiklund, Jesper P. (Index Pharmaceuticals 201109– CEO before Sobi before Affectis + Evotec OAI + DeveloGen + Elan) |
Chief Executive Officer (CEO) |
InDex Pharmaceuticals (Group) |
Stockholm |
| Wiest, Joachim (Cellasys GmbH 201201 Managing Director) |
Managing Director |
Cellasys GmbH |
Kronburg |
| Wiest, Christian (iThera Medical 201110 Managing Director) |
Managing Director |
iThera Medical GmbH |
Neuherberg |
| Wiese, Hanns-Peter (Global Life Science Ventures 201105 Managing Director) |
Managing Director |
Global Life Science Ventures (Group) |
München (Munich) |
| Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Ebersberg |
| Wichert, Sven (Systasy Bioscience GmbH 201405 Managing Director + Co-Founder) |
Managing Director |
Systasy Bioscience GmbH |
München (Munich) |
| Wibbelmann, Jobst (Wuesthoff & Wuesthoff 200809 Munich) |
n. a. |
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte (Munich) |
München (Munich) |
| Werner, Thomas (Genomatix 200609 CEO + CSO) |
Chief Executive Officer (CEO) |
Genomatix Software (Group) |
München (Munich) |
| Weller, Ulrich (Labor Boogen Köln 200909 Head Microbiology) |
Laboratory Manager (industry) |
Praxis für Laboratoriumsmedizin, Hämostaseologie Dr. med. Christiane Boogen (Labor Boogen Köln) |
Köln (Cologne) |
| Weitemeyer, Nathalie (Bayern Kapital 201112 Senior Investment Manager) |
Investment Manager |
Bavaria (govt region) |
Landshut |
| Weiser, Weishui (Coral BioNet 2006c–201102 CEO Scil Technology GmbH retired 2/00) |
Chief Executive Officer (CEO) |
Coral BioNet (Group) |
Martinsried |
| Weiner, Olaf (directif GmbH 200503 Managing Director) |
Chief Executive Officer (CEO) |
November (Group) |
Erlangen |
| Weinberger, Klaus (Bavarian Nordic 201202 VP R&D at Bavarian Nordic GmbH before Biocrates CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bavarian Nordic (Group) |
Martinsried |
| Weilermann, Wolfgang (NascaCell 200809 Chairman Supervisory Board) |
Board member, non-executive |
NascaCell (Group) |
München (Munich) |
| Weil, Ingrid (Fidura Private Equity Fonds 201311 Managing Director of IWF Fondsconsult GmbH) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Grünwald |
| Weidner, Gerhard |
n. a. |
Geneworx AG |
Oberhaching |
| Weichselgartner, Michael |
n. a. |
Eurofins (Group) |
Ebersberg |
| Wehselau, Stephan (Xantos 200309 promoted to CEO) |
Chief Executive Officer (CEO) |
Xantos Biomedicine AG |
Martinsried |
| Wedershoven, Volker (Imevax GbmH 201410– Managing Director) |
Managing Director |
Imevax GmbH |
München (Munich) |
| Wedel, Adolf (PhytoLab GmbH & Co KG 201208 Managing Director) |
Managing Director |
Martin Bauer Group (Group) |
Vestenbergsgreuth |
| Watzke, Harald (MorphoSys 200704 Head Alliance Management) |
Business Development Manager / Strategy Manager |
MorphoSys (Group) |
Martinsried |
| Wassill, Lars (Amplex Diagnostics 200810) |
n. a. |
AmplexDiagnostics GmbH |
Markt Gars a. Inn |
| Wandersee, Christian (Vasopharm GmbH 201306 Managing Director) |
Managing Director |
Vasopharm GmbH |
Würzburg |
| Walter, Monika (Hyglos 2010 Manager Operations) |
Chief Operating Officer (COO) |
Mérieux (Group) |
Bernried |
| Walser, Rudolf (LTF-Labortechnik 200512) |
Sales Manager / Marketing Manager |
LTF Labortechnik (Group) |
Wasserburg (Bodensee) |
| Waldmann, Thomas (Proteros 201110 Director Business Development before Sloning 200607–201108– BusDev Manager) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
Martinsried |
| Walch, Axel (Helmholtz 200905 Pathologist at Helmholtz Centre Munich) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Neuherberg |
| Wagner-Solbach, Volker (AMSilk 201704– Procurement + Supply Chain Manager before AVA-CO2 AG + Bayern Innovativ GmbH) |
management (personnel) |
AMSilk GmbH |
Martinsried |
| Wagner, Ralf (Lophius 201301– Managing Director before Geneart AG 1999– founder + CEO + CSO) |
Managing Director |
Lophius Biosciences GmbH |
Regensburg |
| Wagner, Christina (Ventac Partners 201302 Senior Advisor before Inveni Capital 200904 Inveni Capital GmbH) |
n. a. |
SilverSky (Group) (Silversky Lifesciences) |
Düsseldorf |
| Wagener, Michael (Bio-Gate AG 201104 CTO) |
Chief Technology/Technical Officer (CTO) |
Bio-Gate (Group) |
Nürnberg (Nuremberg) |
| Wacker, Peter-Alexander (Wacker 200501 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
München (Munich) |
| Wachenfeld, Joachim (Vossius & Partner 200310–200708–) |
n. a. |
Vossius & Partner patent attorneys |
München (Munich) |
| Völker, Sonja (Bayern (govt) 201301 Project Manager at IBB Netzwerk GmbH) |
n. a. |
Bavaria (govt region) |
Martinsried |
| Vornlocher, Hans-Peter (Roche Kulmbach 200809 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Axolabs GmbH |
Kulmbach |
| von Velasco, Sabine (ERC GmbH 201106 Marketing) |
Sales Manager / Marketing Manager |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Riemerling |
| von Schacky, Clemens (Omegametrix GmbH 201807 Managing Director) |
Managing Director |
Omegametrix GmbH |
Martinsried |
| von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Köln (Cologne) |
| von Klitzing, Bettina (4SC 200901 Manager Public Realtions & Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Martinsried |
| von Einem, Christoph (White & Chase 200809 Munich) |
n. a. |
White & Case (Group) |
München (Munich) |
| Voglmaier, Manfred (Definiens –200411–200810 VP BusDev Life Sciences) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
München (Munich) |
| Vogeser, Gudrun (PIKA Weihenstephan GmbH 201308 Managing Director + Co-founder) |
Managing Director |
PIKA Weihenstephan GmbH |
Bayern_o |
| Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) |
Chief Executive Officer (CEO) |
Immunic AG |
Martinsried |
| Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) |
Chief Technology/Technical Officer (CTO) |
Apceth (Group) |
München (Munich) |
| Van den Brulle, Jan (Sloning BioTechnology 201004 Scientific Director R&D) |
Research & Development Manager |
MorphoSys (Group) |
Puchheim |
| Valor, Santiago (Synlab 201603 CMO) |
Chief Medical Officer (CMO) |
Synlab (Group) |
Augsburg |
| Ungerer, Martin (Corimmun 2006 Co-founder before Procorde) |
Company Founder |
Johnson & Johnson (JnJ) (Group) |
Martinsried |
| Ulyanova, Elena (Entelechon 201208 Business Development + Marketing Manager at PolyQuant GmbH) |
Business Development Manager / Strategy Manager |
PolyQuant GmbH |
Bad Abbach |
| Ullrich, Axel (Max Planck 201102 Director MPI for Biochemistry, Dept. of Molecular Biology) |
Professor |
Max Planck Society for the Advancement of Science |
Martinsried |
| Ullmann, Dirk (Proteros Biostructures 200903– CSO before Evotec Service Division for 11 years) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteros (Group) |
Martinsried |
| Ullerich, Lars (GNA Biosolutions GmbH 201507 Managing Director) |
Managing Director |
GNA Biosolutions GmbH |
Martinsried |
| Uhl, Nikolaus (Weitnauer Rechtsanwälte 200809 Berlin) |
n. a. |
Weitnauer Rechtsanwälte Wirtschaftsprüfer Steuerberater |
München (Munich) |
| Ueffing, Marius (Helmholtz 201202 Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Neuherberg |
| Tuschl, Thomas (Rockefeller Univ 200601) |
n. a. |
Axolabs GmbH |
Kulmbach |
| Tudorica, Joanne (Trophic Communications 201801 before MacDougall Biomedical Communications) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
München (Munich) |
| Tostmann, Holger (Trophic Communications GmbH 201710– Managing Director) |
Managing Director |
Trophic Communications GmbH |
München (Munich) |
| Thormann, Michael (Origenis 200609 Managing Director) |
Managing Director |
Origenis (Group) |
Martinsried |
| Thome, Rainer (Univ Würzburg 200810 Prof BWL + Wirtschaftsinformatik) |
Professor |
University of Würzburg |
Würzburg |
| Thomas, Ralf P. (Siemens 201711 CFO) |
Chief Financial Officer (CFO) |
Siemens (Group) |
München (Munich) |
| Thirion, Christian (Sirion Biotech 201106 Managing Director CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sirion Biotech GmbH |
Martinsried |
| Thestrup, Thomas Michael (Sunstone Capital 201509– Associate before Denmark (govt) Consultant Life Science ICD Munich) |
Investment Manager |
Sunstone Capital A/S |
København (Copenhagen) |
| Theoharis, Stefanos (Apceth 201309– CBO before Antisense Pharma + Roche + Lazard) |
Chief Business Officer (CBO) |
Apceth (Group) |
München (Munich) |
| Thelen, Tobias (Altmann Analytik 201312 Managing Director) |
Managing Director |
Altmann Analytik (Group) |
München (Munich) |
| Tetko, Igor (eADMET GmbH 201109 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
eADMET GmbH |
Neuherberg |
| Terhart, Peter (S-Refit 200503) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Regensburg |
| Teetz, Wolfram (eADMET GmbH 201109 Managing Director) |
Managing Director |
eADMET GmbH |
Neuherberg |
| Tebbe, Andreas (Kinaxo 200708– Head Mass Spectrometry before post doc scientist at Roche Research Centre) |
Head Mass Spectrometry / NMR Laboratory (industry) |
Evotec (Group) |
Martinsried |
| Taapken, Thomas (Medigene 201701–201808 CFO before Epigenomics + Biotie/elbion + DVC + Burrill + Hoechst LEFT 8/18) |
Chief Financial Officer (CFO) |
Medigene (Group) |
Martinsried |
| Supper, Jochen (Genomatix Software 201211 Head Computational Biology) |
n. a. |
Genomatix Software (Group) |
München (Munich) |
| Sundermann, Martin (Osborne Clarke 201612) |
Attorney / Lawyer |
Osborne Clarke (Group) |
München (Munich) |
| Stölzle-Feix, Sonja (Nanion 201309 Senior Scientist) |
Researcher (industry) |
Nanion (Group) |
München (Munich) |
| Stubbers, Ron (InGeneron 201710 Head of Operations) |
Chief Operating Officer (COO) |
InGeneron (Group) |
München (Munich) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
Person
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px](/banner/iito-20150529-600-080-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
